Analysis on the Utilization of Drug for Bony Metastasis Cancer in Our Hospital from 2006 to 2009
- VernacularTitle:我院2006～2009年治疗恶性肿瘤骨转移药应用分析
- Author:
Dan YAN
;
Ning GAO
- Publication Type:Journal Article
- Keywords:
Bony metastasis;
DDDs;
Diphosphonate
- From:
China Pharmacy
2005;0(14):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the status quo and tendency of the utilization of drug for bony metastasis cancer in our hospital. METHODS:The utilization of drug for bony metastasis cancer in our hospital from 2006 to 2009 was analyzed statistically. RESULTS:The total amount of the drug for bony metastasis cancer had been increasing. Pamidronate took up the first place of the consumption sum list and accounted for 80% of total consumption sum. Top one drug in the list of DDDs was domestical pamidronate. Utilization rate of disodium clodronate increased form 0.67% in 2006 to 31.68% in 2009. The order of DDC had not changed during 2006～2009. CONCLUSION:In recent year the drug for bony metastasis cancer has been rational and has become curative effect-oriented rather than price-oriented.
